Group | N | Mean LDL-C at Baseline (mg) | Mean LDL-C at Follow up (mg) | Mean Reducing percentage | Actual range of reducing percentage | Duration (month) |
---|---|---|---|---|---|---|
≤70 mg | 1250 | 120.0±8.2 | 60.6±3.5 | 48.8±3.3 | 37~53.2 | 18.6±8.2 |
>70≤100HP mg | 1352 | 132.4±12.9 | 77.8±7.0 | 40.4±4.0 | 32.3~46.7 | 17.4±5.9 |
>70≤100MP mg | 1548 | 91.3±6.9 | 82.4±8.2 | 9.1±4.5 | 3.6~14.9 | 19.8±2.7 |
>70≤100LP mg | 1061 | 88.5±5.5 | 91.5±5.4 | -4.7±2.5 | -1.7~-8.5 | 19.9±4.5 |
>100 mg | 699 | 125.1±24.4 | 110.0±9.3 | 8.3±15.6 | -10.9~32 | 14.6±5.1 |
<0% | 1276 | 89.1±5.3 | 93.2±6.2 | -5.6±3.1 | -1.7~-10.9 | 19.6±4.2 |
>0≤30% | 2014 | 102.4±22.1 | 89.7±15.7 | 10.6±7.3 | 0~25 | 18.3±4.5 |
>30≤40% | 594 | 132.6±11.4 | 83.3±7.7 | 36.1±1.9 | 32~39 | 10.3±3.1 |
>40≤50% | 1677 | 123.7±13.4 | 66.8±8.0 | 45.4±2.8 | 41.5~49 | 19.4±6.9 |
>50% | 349 | 130.4±34.3 | 60.8±20.0 | 53.2 | 53.2 | 24 |